Study of IBI3009 in Participants with Unresectable, Metastatic or Extensive-Stage Small Cell Lung Cancer
Clinical trial NCT06613009 · RECRUITING
Trial details
- NCT number
- NCT06613009
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-30
- Primary completion
- 2027-08-30
- Enrollment
- 190
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.